BRKR (BRKR) Stock Analysis
Verdict: HOLD
Goodwill impairments mask underlying 5.2% organic growth, but high debt and insider selling suggest the post-crash floor isn't yet firm.
Investment score: 48/100
The AI model recommends a HOLD. While the 20% haircut reflects a significant goodwill impairment, the underlying 36% revenue growth and 46.7% gross margins remain intact. However, the valuation (68x EV/EBITDA) is still expensive relative to BIO (149x) and RGEN (70x) when adjusted for Bruker's significantly higher leverage.
Peers
| Peer | P/E | P/B | P/S | EV/EBITDA | ROIC % | Net margin % |
|---|---|---|---|---|---|---|
| CRL | -48.27 | 4.00 | 2.82 | -489.07 | — | -0.06 |
| AVTR | -16.31 | 1.64 | 1.41 | 455.98 | — | -0.09 |
| BIO | 39.94 | 1.24 | 3.47 | 149.22 | — | 0.09 |
| TEM | -32.90 | 19.03 | 5.76 | -99.97 | — | -0.18 |
| RGEN | 202.41 | 4.00 | 10.77 | 70.07 | — | 0.05 |